A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations
- 26 May 2020
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (5), 2000205
- https://doi.org/10.1183/13993003.00205-2020
Abstract
Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, including the pancreas, hepatobiliary system and reproductive organs however lung disease is responsible for the majority of morbidity and mortality. Management of CF involves CFTR modulator agents including corrector drugs to augment cellular trafficking of mutant CFTR as well as potentiators that open defective CFTR channels. These therapies are poised to help most individuals with CF, with the notable exception of individuals with class I mutations where full length CFTR protein is not produced. For these mutations, gene replacement has been suggested as a potential solution. In this work, we used a helper dependent adenoviral vector (HD-CFTR) to express CFTR in nasal epithelial cell cultures derived from CF subjects with class I CFTR mutations. CFTR function was significantly restored in CF cells by HD-CFTR and reached healthy control functional levels as detected by Ussing chamber and membrane potential (FLIPR) assay. A dose response relationship was observed between the amount of vector used and subsequent functional outcomes; small amounts of HD-CFTR were sufficient to correct CFTR function. At higher doses, HD-CFTR did not increase CFTR function in healthy control cells above baseline values. This latter observation allowed us to use this vector to benchmark in vitro efficacy testing of CFTR-modulator drugs. In summary, we demonstrate the potential for HD-CFTR to inform in vitro testing and to restore CFTR function to healthy control levels in airway cells with class I or CFTR nonsense mutations.Keywords
Funding Information
- Emily's Entourage
- Sick Kids Foundation
- Canadian Institutes of Health Research
- Cystic Fibrosis Canada
This publication has 52 references indexed in Scilit:
- Transcriptional regulation of CFTR gene expressionFrontiers in Bioscience-Elite, 2012
- Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppressionGene Therapy, 2010
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences, 2009
- Basal cells as stem cells of the mouse trachea and human airway epitheliumProceedings of the National Academy of Sciences of the United States of America, 2009
- Cystic fibrosis transmembrane conductance regulator (CFTR) dependent cytoskeletal tension during lung organogenesisDevelopmental Dynamics, 2006
- Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheterThe Journal of Gene Medicine, 2005
- The CFTR gene and regulation of its expressionPediatric Pulmonology, 2005
- Challenges and Strategies for Cystic Fibrosis Lung Gene TherapyMolecular Therapy, 2001
- Evaluation of the Efficacy and Safety ofIn Vitro, Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNAHuman Gene Therapy, 1994
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989